See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $38.6B | 2.3x | 8.0x | |
| $3.5B | 7.2x | 21.9x | |
| $3.4B | 18.8x | 51.9x | |
| $3.1B | 34.1x | -28.0x | |
| $2.4B | 2.9x | 14.3x | |
| $2.4B | 10.5x | -10.2x | |
| $2.1B | 0.8x | 6.0x | |
| $1.9B | 69.6x | -52.9x | |
| $1.9B | 8.3x | 19.7x | |
| $1.4B | 6.2x | 27.3x | |
| $1.3B | 5.3x | 15.7x | |
| $1.1B | 5.4x | 25.8x | |
| $1.0B | n/a | n/a | |
| $922M | n/a | n/a | |
| $753M | 3.4x | 59.0x | |
| $679M | 7.9x | 22.3x | |
| $655M | 8.8x | -8.1x | |
| $644M | 5.5x | n/a | |
| $555M | 4.2x | -14.0x | |
| $520M | 2.0x | 5.3x | |
| $427M | 4.1x | n/a | |
| $401M | n/a | -3.2x | |
| $393M | 173.5x | -47.3x | |
| $369M | 47.1x | n/a | |
| $339M | n/a | -17.0x | |
| $293M | 2.7x | -150.4x | |
| $289M | 1.1x | 9.6x | |
| $271M | 20.3x | n/a | |
| $159M | n/a | n/a | |
| $151M | 20.1x | n/a | |
| $142M | n/a | -5.6x | |
| $132M | 5.3x | -5.4x | |
| $95.1M | 1.6x | n/a | |
| $81.3M | 8.1x | n/a | |
| $77.3M | 2.8x | -0.7x | |
| $44.9M | n/a | -0.5x | |
| $33.6M | 28.7x | n/a | |
| $22.6M | 72.9x | n/a | |
| -$159M | -14.1x | 0.9x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules